Lumet HS

Lumet HS is a fixed-dose combination antimalarial drug developed and manufactured by Quality Chemicals Industries Limited (QCIL) in Uganda. It is a higher-dose formulation containing 80 mg of artemether and 480 mg of lumefantrine in a single oral tablet, designed for adults and children weighing over 35 kg. Artemether, an artemisinin derivative, provides a rapid onset of action by interfering with heme metabolism and damaging parasite biomolecules, leading to quick symptomatic relief. Lumefantrine acts as a long-acting blood schizonticide that clears residual parasites to prevent recrudescence. This combination therapy is indicated for the treatment of uncomplicated malaria caused by *Plasmodium falciparum* and other *Plasmodium* species, and is particularly effective against chloroquine-resistant strains.

Brand names

Lumet HSLumet HS 80

Other names

artemether + lumefantrineAL